Barclays and Deutsche begin Evonik buyout syndication

Barclays and Deutsche Bank have started syndicating the debt backing Advent’s buyout of Evonik’s methacrylates business, a deal which almost escaped the market earlier this year when GSO offered to provide the whole package.

  • By Owen Sanderson
  • 20 May 2019

The acquisition loans will include a €965m term loan 'B', a €520m-equivalent dollar term loan 'B', and a €300m multi-currency revolver to fund the spin-off of a business which will be known as Madrid from chemical firm Evonik.

The loans were talked at 475bp for the dollars and 500bp ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 7,151.10 53 6.42%
2 Deutsche Bank 6,886.84 39 6.18%
3 Goldman Sachs 6,877.67 36 6.18%
4 Credit Agricole CIB 6,659.77 36 5.98%
5 Barclays 6,209.03 28 5.58%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 19 Aug 2019
1 Citi 4,728.01 24 9.17%
2 JPMorgan 3,649.83 29 7.08%
3 Deutsche Bank 3,638.27 22 7.06%
4 Barclays 3,441.80 22 6.68%
5 Goldman Sachs 3,389.62 26 6.58%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 18,847.11 143 9.44%
2 JPMorgan 18,279.02 147 9.16%
3 Goldman Sachs 14,831.56 109 7.43%
4 Bank of America Merrill Lynch 14,255.85 117 7.14%
5 Morgan Stanley 12,912.93 86 6.47%